Skip to main content

Team Maureen


Cervical Cancer

An Interactive Educational Tool to Improve Human Papillomavirus Vaccine Knowledge and Recommendation Among Nurses

Healthcare provider education has been associated with strong vaccine recommendation and vaccination uptake. Our objective was to create a 7-min interactive online educational tool to improve knowledge and willingness to recommend the HPV vaccine among nurses. Eighty-five percent of participants using the tool strongly agreed that the intervention improved their HPV knowledge, and 77% stated they were more likely to recommend the HPV vaccine after the intervention.

HPV vaccination substantially reduces risk for invasive cervical cancer

Quadrivalent human papillomavirus (HPV) vaccination was associated with a substantial reduction in the incidence of cervical cancer in a Swedish review of more than 1 million girls and women vaccinated from 2006–2017.

With Vaccination and Screening, Cervical Cancer Could All But Disappear in North America by 2040

Cervical Cancer Mortality Rises as Women's Health Clinics Close

Cervical cancer declined dramatically in recent years in the United States, both in incidence and mortality, due to widespread availability of screening. But now researchers are reporting a trend toward more women being diagnosed with late-stage disease and significantly increased mortality.

The trend follows the closure of nearly 100 women's health clinics across the country from 2010 to 2013. This has led to an associated decrease in screening for cervical cancer and fewer women being diagnosed with early-stage disease

Fighting the Good Fight Against HPV and Cervical Cancer

An Indianapolis family advocates for HPV vaccination after losing their daughter to cervical cancer.

Wrong information creating ‘dangerous screening gap’ in cervical cancer

NHS England is warning that the misconception that lesbian, gay and bisexual (LGB) women are not at risk of cervical cancer is putting 50,000 LGB women at risk.

The ‘fake news’ has created a dangerous screening gap, as the affected women have never been for a cervical cancer screening test because they wrongly think they are not at risk.

Continue to Article

When is HPV a Problem?

There are more than 200 types of human papillomavirus, or HPV, about 40 of which can be spread sexually. The Gardasil vaccine, which is given to both men and women, protects a person from seven of the most high-risk (cancer-causing) types of HPV, as well as the two types that cause most genital warts. Most people who contract HPV will get rid of the virus on their own, but those who don’t are at risk for cancer and genital warts. This vaccine is vital in the war against HPV.

Addressing Cervical Cancer Globally Requires Scaling Up HPV Vaccination, Expanding Screening, Treatment For Women

We Have the Resources to Prevent Cervical Cancer. Do We Have the Will?
“…Although cervical cancer is the fourth most common cancer for women globally, claiming more lives than pregnancy and childbirth, we can save those lives if we can only summon the will. Health experts say that the battle against cervical cancer has two fronts. First, we need to scale up HPV vaccination to prevent cervical cancer. Second, we need to expand screening and treatment for women now in danger. These are relatively affordable, straightforward interventions that can make a big difference in a lot of lives.

Rwanda has fought to stamp out cervical cancer – they might just be the first country to do it

As Rwanda gears up for a new round of vaccinations later this year, the immunologist responsible for the vaccine that has saved so many women’s lives believes the world cannot be complacent. “You can’t be happy until everyone has been vaccinated,” Frazer says.

How Artificial Intelligence Can Detect Cervical Cancer

Researchers have developed a computer algorithm that they say can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention. This artificial intelligence approach, called automated visual evaluation, has the potential to revolutionize cervical cancer screening, particularly in low-resource settings.

Women With Select Subtypes of HPV at Higher Risk for Developing High-Grade Cervical Cancer

The nested case-control Swedish study, published in Cancer, found that the presence of specific subtypes of HPV, namely HPV-16 and -18, were associated with a higher risk of developing high-grade cervical intraepithelial neoplasia (CIN) in women under the age of 30.

Hokies and Hoos take on cervical cancer treatment

Virginia Tech scientist Tim Long and University of Virginia oncologist Tim Showalter have teamed up to find a solution to alleviate stress and discomfort for women during cancer treatment.

New epigenetic cervical cancer test has 100 % detection rate

A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study led by Queen Mary University of London.

Black Women in Alabama Dying of Preventable Cancer at Alarming Rate

Black women in Alabama are dying of cervical cancer at more than twice the national average, a trend that appears to be increasing despite the disease being preventable and curable if detected early, a new Human Rights Watch report shows.

Black Women in Alabama Dying of Preventable Cancer at Alarming Rate

Cervical cancer, a disease researchers believe is on track to be eradicated within 20 years in some industrialized nations, is killing a disproportionate number of women across the American south.

Australia is about to eradicate cervical cancer, US is nowhere close. What'll it take?  

Researchers announced last month that thanks to a compulsory vaccine program, Australia is on track to eradicate cervical cancer. This is due to almost universal vaccination against human papillomavirus (HPV), a virus which isresponsible for 90 percent of cervical cancers.

Australia is about to eradicate cervical cancer, US is nowhere close. What'll it take?

WHO leads the way towards the elimination of cervical cancer

Cervical cancer is a grave threat to women’s health and lives, and globally, one woman dies of cervical cancer every two minutes. This suffering is unacceptable, particularly as cervical cancer is largely preventable.

New Clinical Trials Test Immunotherapy for Cervical Cancer

Immunotherapy has brought promising breakthroughs for several forms of cancer. Now, researchers are applying the knowledge they’ve gained in previous clinical trials as they look into how immunotherapy might provide additional treatment options for patients with recurrent cervical cancer.

Patients being turned away from sexual health clinics, RCN says

New Clinical Trials Test Immunotherapy for Cervical Cancer

Immunotherapy has brought promising breakthroughs for several forms of cancer. Now, researchers are applying the knowledge they’ve gained in previous clinical trials as they look into how immunotherapy might provide additional treatment options for patients with recurrent cervical cancer.

Two Women Are Building A Pregnancy Test-Like Device To Spot Cervical Cancer

One in every 100 women in Europe will develop cervical cancer.

If diagnosed early, this can be treated. Undiagnosed, it spreads into other parts of the body - leading ultimately to death.

Yet life-saving cervical cancer screening is today at an all-time low, with many women skipping so-called ‘PAP smears’ to avoid potential discomfort at the doctors.

Could Making Cancer Screening Simpler Increase Women's Risk?

A proposal to simplify cervical cancer screening could end up missing some cancers, researchers and patient advocates say. And that could be especially true for minority women.

Sweetening connection between cancer and sugar

Scientists have found that some types of cancers have more of a sweet tooth than others.

What you should know about Cervical Cancer

Unlike many gynecologic cancers, there is a vaccination and screening test for cervical cancer, an important distinction in preventing and identifying the disease, according to Ursula Matulonis, MD, medical director of Gynecologic Oncology in Dana-Farber’s Susan F. Smith Center for Women’s Cancers, and Colleen Feltmate, MD, director of minimally invasive surgery in Gynecologic Oncology at Brigham and Women’s Hospital.

Cervical cancer is killing women at a higher rate than previously thought

Women’s risk of dying from cervical cancer may be much greater than medical professionals originally thought, according to a new study.

Wider Racial Gap Found in Cervical Cancer Deaths

The death rate from cervical cancer in the United States is considerably higher than previously estimated and the disparity in death rates between black women and white women is significantly wider, according to a study published Monday in the journal Cancer.

Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond

Despite the declining incidence of cervical cancer as a result of the introduction of screening programs, globally it remains a leading cause of cancer-related death in women. Outcomes for patients who are diagnosed with anything but early-stage disease remain poor.

11 Things You Never Knew to Ask Your Gyno About Cervical Cancer

But just because this gynecologic cancer occurs less frequently doesn’t mean it’s less deadly.  In fact, cervical cancer was once the No. 1 leading cause of cancer death for women in the US. What’s worse? The disease is almost 100 percent preventable. This fact is especially chilling for Latinas, who have the highest incidence of cervical cancer and the second-highest death rate from the disease.

Half of young women unable to ‘locate vagina'

Half of young women are unable to properly label a vagina on a medical diagram, while 65 per cent have admitted they have a problem simply using the words vagina or vulva.

FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer

From the link:
Avastin works by interfering with the blood vessels that fuel the development of cancerous cells. The new indication for cervical cancer is approved for use in combination with chemotherapy drugs paclitaxel and cisplatin or in combination with paclitaxel and topotecan.

Study finds genomic differences in types of cervical cancer

A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type’s molecular idiosyncrasies.........
.....The research was supported by grants from the American Cancer Society, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Team Maureen Cervical Cancer Fund, and the Friends of Dana-Farber Cancer Institute.

HPV News

Factors Associated with Human Papillomavirus Vaccine Initiation and Compliance Among U.S. Military Service Members

The primary objective of the current study was to assess factors associated with Human Papillomavirus (HPV) vaccine initiation and compliance in a cohort of active duty US military service members (SM). HPV vaccination uptake is subpar across all military service branches. Certain subgroups of SMs could be targeted to increase overall HPV vaccine coverage in the US military population.

Feasibility and sustainability of a nurse-led intervention to integrate HPV vaccination into medical processing for active-duty Soldiers

To increase Soldiers' access to HPV vaccination, we evaluated the feasibility and sustainability of a nurse-led intervention to integrate HPV vaccination into medical processing procedures for Soldiers. We partnered with nursing staff to introduce HPV vaccine into existing vaccination services at a nurse-led clinic that serves Soldiers at Fort Bragg, North Carolina. Our findings suggest that training nursing staff to recommend and administer HPV vaccinations to Soldiers is feasible and warrants wider-scale testing as a strategy to protect soldiers from HPV-attributable cancers.

Scientists find new way to block cancer-causing HPV

In a new study published today in the Proceedings of the National Academy of Sciences, Yale Cancer Center (YCC) researchers have demonstrated in principle a new biological approach that can stop HPV .

South Boston Pediatrician nationally recognized for fighting HPV-related cancers

Dr. Thomas Schuch was awarded the HPV Vaccine is Cancer Prevention Champion Award by the Center for Disease Control and Prevention (CDC), American Cancer Society (ACS), and the Association of American Cancer Institutes (AACI). The award recognizes clinicians, clinics, practices, groups, and health systems that go above and beyond to encourage HPV vaccination in their communities.

HPV Blamed for Rising Rates of Anal Cancer

HPV-related anal cancer has been on the rise over the past 15 years, according to a new study published in the Journal of the National Cancer Institute.

Most American Adults Are Unaware of HPV-Related Cancers, Indicating Need for Heightened Awareness

According to a new study published last week in the journal JAMA Pediatrics, more than 70% of US adults do not know that HPV can cause oral, anal, and penile cancers.

Stopping the Anxiety of HPV

How a woman found emotional support after an HPV diagnosis. Continue to Article

Cancer and the Transgender Community

New, but limited, research suggests that the burden of cancer disproportionately affects sexual and gender minorities disproportionately more than their heterosexual counterparts. Continue to Article

5 Things You Didn’t Know About HPV—The Most Common STD

If you’ve been putting off getting your pap smear, there’s one big reason you should make that appointment: the human papillomavirus. According to the Centers for Disease Control and Prevention, around 79 million Americans are currently infected with HPV and approximately 14 million people become newly infected every year, making it the most common STD.

A Cure for HPV? Evaluating HPV Treatment Options

If you’ve had an HPV diagnosis, you may have seen claims like this in your search for information on the Internet and elsewhere, often written in large bold type. In smaller type are the disclaimers:

Marcia Cross Is Sharing Her Anal Cancer Story in the Hopes of Ending the ‘Stigma’

"There is a lot of shame about it. I want that to stop," the actress tells PEOPLE...

Study Ties Cancer-Causing HPV to Heart Disease, Too

Certain strains of HPV are known to cause cervical cancer and other types of tumors. Now, a new study raises the possibility that they might also contribute to heart disease.

Researchers found that among over 63,000 women, those infected with "high-risk" strains of human papillomavirus (HPV) were somewhat more likely to develop heart disease or suffer a stroke over the next several years.

At-home HPV tests could be powerful tool for hard-to-reach U.S. women

Screening women for HPV, or human papillomavirus, is a promising way to help detect cervical cancer early, but many at-risk women go without screening for the virus and without Pap tests that look for abnormal cells on the cervix.

A new study from The Ohio State University found that mailing at-home HPV tests to hard-to-reach women may be a viable approach, one that could be especially helpful in regions such as Appalachia, where access to women’s health care can be limited.

At-home HPV tests could be powerful tool for hard-to-reach U.S. women

Pilot study found 80 percent of participants used the tests A new study from The Ohio State University found that mailing at-home HPV tests to hard-to-reach women may be a viable approach, one that could be especially helpful in regions such as Appalachia, where access to women’s health care can be limited.

10 myths about HPV

Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer.

The rising incidence rate of oropharyngeal cancer in men and the decreasing, but relatively high, incidence rate of cervical cancer in women highlight the need for further screening and prevention by HPV vaccination in Massachusetts.

Prevalence of Genital Human Papillomavirus Infection

Question  What are the prevalence of both genital human papillomavirus (HPV) infection and the HPV vaccination rate among adult men in the United States?

Meaning  Male HPV vaccination may have a greater effect on HPV transmission and cancer prevention in men and women than previously estimated.

Gardasil HPV Vaccine Safety Assessed In Most Comprehensive Study To Date

The largest review of the available evidence on the quadrivalent, or four-strain, HPV vaccine Gardasil, has found no evidence of any serious short-term or long-term safety issues. Bringing together the findings from clinical trials, post-licensure studies and data presented at scientific meetings but not yet published, the researchers focused particularly on autoimmune diseases, nervous system disorders, anaphylaxis, blood clots and stroke – but none of them is caused by the vaccine, they found.

College Kids Don’t Understand the HPV Threat

Many American college students don't get vaccinated against human papillomavirus (HPV), and many don't fully understand the threat posed by the virus or their risk for infection, new findings suggest.

HPV Vaccination Not Linked to Riskier Sex

Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a low uptake, partly because of concerns about how it will affect adolescent sexual activity.

BUSM study highlights strategies to promote HPV vaccinations

About 79 million Americans are currently infected with human papillomavirus, a commonly overlooked sexually transmitted infection, with an estimated 14 million more infected each year, according to the Centers for Disease Control and Prevention. Inevitably, these numbers beg the clinical question: How can HPV be prevented?

Scientists Develop New Way to Treat HPV-Related Cancer

A drug called cidofovir that’s already used to target viruses could also be used as part of a novel way to treat cervical cancer

HPV infection found to increase risk of lung cancer

According to a new study published in the Journal of Clinical Virology, researchers have found that there is a strong association between lung tissue with human papillomavirus (HPV) infection, particularly HPV subtypes 16 and 18, and lung cancer.

Oral Human Papillomavirus (HPV) Infection Risk Increased by Three Daily Cigarettes

According to a new study published in the Journal of the American Medical Association, researchers at the Johns Hopkins Boomberg School of Public Health in Baltimore, Maryland, have found that cigarette smokers are more likely to be positive for human papillomavirus (HPV)-16 compared with non-smokers.

Cervical HPV Urine Test Demonstrates Accuracy

A simple urine test can routinely spot human papillomavirus (HPV), according to research published in The BMJ.

Someone You Love: The HPV Epidemic

Narrated by Vanessa Williams. The Human Papilloma Virus HPV may be the most widespread, misunderstood and potentially dangerous epidemic that most people hardly know anything about. 80 percent of all people under 50 years of age will have a strain of the virus at some point in their lives and most will not even realize they have it. Cervical cancer is almost exclusively caused by HPV and it is the 2nd leading cancer in women. Worldwide, cervical cancer kills over 250,000 women every year. Meet five unforgettable women whose lives have been changed forever and even interrupted by this deadly virus.

HPV Piece by Paul Offit: Let's Not Talk About Sex

From the article:
In a typical year in the United States about 150 people die from meningococcus, four from tetanus, none from diphtheria, 20 from pertussis, and roughly 4,000 from cancers caused by HPV. People are more than 20 times more likely to die from HPV than from the other four diseases combined.

Vaccine News

A 20-year study on dozens of vaccines finds they are safer than 'almost any other modern medical intervention'

A comprehensive new study spanning 20 years and 57 vaccines finds vaccines are "remarkably safe" — safer, in fact, than "almost any other modern medical intervention," lead author Dr. Daniel Shepshelovich told Business Insider.

For the study, he and other researchers at Tel Aviv Sourasky Medical Center looked at the labels, including safety-related changes, of 57 vaccines that became FDA-approved between the beginning of 1996 and end of 2015.

Vaccine Rates Drop Dangerously as Parents Avoid Doctor’s Visits

Afraid of Covid-19, parents are postponing well-child checkups, including shots, putting millions of children at risk of exposure to preventable deadly diseases.

Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types

More than a decade after vaccination, women who had received a single dose of human papillomavirus (HPV) vaccine continued to be protected against cervical infection with the two cancer-causing HPV types targeted by the vaccine, HPV16 and 18. The new findings are from an extended follow-up of the NCI-sponsored Costa Rica HPV Vaccine Trial.

Take the Shot Nights at Falmouth High School and Mashpee High School

Taking a Shot at HPV Prevention!

Young fans who attend the Falmouth High girls’ basketball game on Jan. 31 and the Mashpee High boys’ basketball game on Feb. 14 will have the opportunity to spin a prize wheel and participate in a halftime basketball free-throw contest.

At the 3rd Annual “Take the Shot Night,” they will also, along with their parents/guardians, learn about a different shot that will protect them from the HPV virus and HPV-related cancers.

Years after Texas backed off HPV vaccine mandate, cervical cancer rate soars

Texas and Australia took two very different paths in 2007. And the difference is unbelievable. Continue to Article

Human Papillomavirus Vaccination for Adults: Updated Recommendations

Study: HPV Vaccine Works

A new meta-analysis published in The Lancet in June shows the HPV vaccine is very effective and is expected to lower the rate of cervical and other related cancers.

The researchers reviewed data from 60 million young men and women in 14 high-income nations, with up to 8 years of post-vaccination follow-up. Continue to the Cape Cod Health News Article.

British boys will receive HPV vaccine to prevent 'thousands of cancers'

London (CNN)Boys aged 12 and 13 will be offered the HPV vaccine in all British schools from September, in a move health officials say will prevent thousands of cancer cases. Continue to Article

KIDS' HEALTH HPV vaccine benefits 'exceed expectations,' may lead to elimination of cervical cancer

End cervical cancer? The HPV vaccine could do it, study suggests

More than 10 years after it became widely available to the public, a recent analysis of prior studies confirms one thing: The HPV vaccine may be a lifesaver. It could even lead to the outright eradication of cervical cancer. Continue to Article

HPV Vaccines are Reducing Infections, Warts-- Probably Cancer

An analysis covering 66 million young people has found plummeting rates of precancerous lesions and genital warts after vaccination against the human papillomavirus.

How to talk to parents about HPV vaccines

What if scientists created a vaccine to prevent cancer but the public largely ignored it? Sadly, that’s where we are with the human papillomavirus, or HPV, vaccine, one of the few preventive cancer vaccines in existence. Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversation.

Vaccine reduces HPV prevalence among teen girls by 86% in 10 years

Within 10 years of vaccine introduction, HPV prevalence decreased 86% among females aged 14 to 19 years in the United States, and 71% in women aged 20 to 24 years, according to study findings presented at the CDC’s Epidemic Intelligence Service, or EIS, conference.

HPV Vaccine Driving Down Cervical Pre-Cancer Rates

The human papillomavirus (HPV) vaccine is largely responsible for a decline in precancerous cervical lesions among young women in the United States, a new government report shows.

The number of these precancerous lesions detected during screening went down from an estimated 216,000 cases in 2008 to 196,000 cases in 2016, researchers from the U.S. Centers for Disease Control and Prevention found.

Dating after 40? The millions who are should get the HPV vaccine

The HPV vaccine is important for preteens and teenagers. What about older women?

‘Is Gardasil 9 right for me?” my patient asked during a recent office visit.

She is 45, recently divorced from her husband of 20 years and crafting her online dating profile. She’s also wondering whether she is a candidate for the vaccine that protects against nine strains of the human papilloma virus (HPV) — a virus that causes most cervical, oral and anal cancer.

Controversial HPV Vaccine Shown to be Highly Effective in Wiping Out Cervical Cancer

According to the U.S. Centers for Disease Control and Prevention (CDC), rates of CIN2+ (which are high-grade cervical lesions that can become cancer, and are used to measure HPV vaccine impact) declined from 216,000 women in 2008 to 196,000 women in 2016. Over two-thirds of these lesions were linked to one of the nine strains of HPV that the Gardasil 9 vaccine targets.

HPV vaccination ramp up: Where could we be in 50 years?

An Educational Intervention to Improve HPV Vaccination: A Cluster Randomized Trial

Educational interventions delivered within a clinical setting hold promise to improve vaccination behaviors.

No Ovarian Failure Risk After HPV Vaccine, Study Finds

Reduced ovarian function in teen girls is not a potential effect of teen vaccination, found a new study.


Fear of encouraging sexual activity is not a common reason why parents avoid immunizing their kids against the sexually transmitted human papillomavirus, according to a new survey analysis.

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

No Ovarian Failure Risk After HPV Vaccine, Study Finds

No increased risk of primary ovarian insufficiency in girls occurred after they received the HPV, Tdap (tetanus-diphtheria-acellular pertussis), MenACWY (four meningococcal disease types) or inactivated flu vaccines, the Pediatrics study found.

HPV vaccine cuts cancer-causing infection

There has been a significant fall in the number of cases of HPV, the virus that causes cervical cancer, following the introduction of a vaccine for young women, a new study says.

HPV Vaccine Cuts Cancer Causing Infection

Doctors Can Increase Vaccination Rates In Kids Using New Approach, Study Finds

HPV vaccines prevent cervical cancer, global review confirms

Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination

Disseminating this intervention widely among primary care professionals could substantially increase national adolescent HPV vaccination levels, particularly among boys.

Effect of Health Care Professional Communication Training on Adolescent HPV

Florida man shares story of how he survived HPV cancer

Jason Mendelsohn was pondering a question during a financial exam in 2014 when his fingers grazed his neck, making him notice a bump he hadn’t felt before.

He consulted his father, a doctor, who told him they’d need to call an ear, nose and throat physician. This led to a doctor’s consultation, which eventually led to a diagnosis. At 44, he was told he had HPV-related throat cancer.

Cancer Prevention Through HPV Vaccination in Your Practice: An Action Guide for Nurses and Medical Assistants

A link to an action guide for providers.

Cancer Prevention Through HPV Vaccination: An Action Guide for Large Health Systems

A link to an action guide for providers.

CDC recommends only two HPV shots for younger adolescents

CDC today recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart rather than the previously recommended three doses to protect against cancers caused by human papillomavirus (HPV) infections. Teens and young adults who start the series later, at ages 15 through 26 years, will continue to need three doses of HPV vaccine to protect against cancer-causing HPV infection.

HPV Sharply Reduced in Teenage Girls Following Vaccine, Study Says

A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, federal researchers said Monday.

Gardasil 9 Indication Now Covers More Male Patients

Merck announced that the Food and Drug Administration (FDA) has expanded the age indication for Gardasil 9 (human papillomavirus 9-valent vaccine [recombinant]) in males. It now includes use in males aged 16–26 for the prevention of anal cancer caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 59; precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58; and genital warts caused by HPV types 6 and 11.

PAS: Communication style influences HPV vaccination

More adolescents received the HPV vaccine when the vaccine was discussed in the context of other vaccines, and when the providers said they expected that the vaccine would be administered at the visit, results from a multisite study suggest.

Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage

Vaccines against human papillomavirus (HPV) are recommended for routine use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal. Educational interventions focused on parents and patients to increase coverage have not generally demonstrated effectiveness.

Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study

The goal of this study was to identify the rationale by parents/guardians and providers for delaying or administering human papillomavirus (HPV) vaccination to girls.

HPV vaccine safe for teens, provides long-term benefits

"When administered to adolescents, the HPV4 vaccine demonstrated durability in clinically effective protection and sustained antibody titers over eight years," concluded the researchers.